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Objectives: Identiﬁcation of those patients with high-risk asymptom-
atic carotid plaques remains an elusive but essential step in stroke preven-
tion. Inﬂammation is a key process in plaque destabilization and the
propensity of atherosclerotic lesions to cause clinical sequelae. There is
currently no clinical imaging technique available to assess the degree of
inﬂammation associated with plaques. This study aims at visualizing and
characterizing atherosclerosis using antibody-conjugated superparamagnetic
iron oxide (SPIO) particles as an MRI probe to assess inﬂammation in hu-
man atherosclerotic plaques.
Methods: Atherosclerotic plaques were collected from 20 consecutive
patients (n = 10 from symptomatic patients, n = 10 from asymptomatic
patients) undergoing carotid endarterectomy (CEA) for extracranial high-
grade internal carotid artery (ICA) stenosis (>70% luminal narrowing).
Inﬂammatory markers on human atherosclerotic plaques were detected
and characterized by ex vivo magnetic resonance imaging (MRI) using
anti-VCAM-1 antibody and anti-E-selectin antibody-conjugated SPIO
with conﬁrmatory immunohistochemistry.
Results: Inﬂammation associated with human ex vivo atherosclerotic
plaques could be imaged using dual antibody-conjugated SPIO by MRI.
Symptomatic plaques could be distinguished from asymptomatic ones by
the degree of inﬂammation, and the MR contrast effect was signiﬁcantly
correlated with the degree of plaque inﬂammation (r = .64, P < .001).
The asymptomatic plaque population exhibited heterogeneity in terms of
inﬂammation. The dual-targeted SPIO-induced MR signal not only tracked
closely with endothelial activation (i.e. endothelial expression of VCAM-1
and E-selectin), but also reﬂected the macrophage burden within plaque le-
sions, offering a potential imaging tool for quantitative MRI of inﬂamma-
tory activity in atherosclerosis.
Conclusions: These functional molecular MRI probes constitute a
novel imaging tool for ex vivo characterization of atherosclerosis at a molec-
ular level. Further development and translation into the clinical arena will
facilitate more accurate risk stratiﬁcation in carotid artery disease in the
future.
Hybrid Treatment of Thoracic, Thoracoabdominal, and Abdominal
Aortic Aneurysms: A Multicenter Retrospective Study
Rosset E., Ben Ahmed S., Galvaing G., Favre J.P., Sessa C., Lermusiaux P.,
Hassen-Khodja R., Coggia M., Haulon S., Rinckenbach S., Enon B.,
Feugier P., Steinmetz E., Becquemin J.P., and the Association
Universitaire de Recherche en Chirurgie. Eur J Vasc Endovasc Surg
2014;47:470-8.
Objectives: The aim of this study was to assess the results of hybrid
techniques for the treatment of thoracic, thoracoabdominal, and abdominal
aortic aneurysms based on multicenter results and the various series
regarding hybrid procedures reported in the literature.
Methods: The results of 76 hybrid procedures performed in 19
French university hospital centers between November 2001 and October
2011 were collected. There were 50 men and 26 women, mean age 68.2
(35-86) years. All patients were considered at high risk (ASA $ 3) for con-
ventional surgery. Aneurysms involved the thoracic, abdominal, and thora-
coabdominal aorta in ﬁve, 14, and 57 cases respectively. There were 11
emergent repairs. The revascularization of four visceral arteries was per-
formed in 38 cases. Between one and three visceral arteries were revascular-
ized in the other cases. Visceral artery debranching and stent graft
deployment were performed in a one-stage procedure in 53 cases and in a
two-stage procedure in 23 cases.
Results: There were 26 (34.2%) postoperative deaths. Nine of the sur-
vivors developed paraplegia, of which one resolved completely. Bowel ischemia
occurred in 13 cases (17.1%), and one patient was treated by a superior mesen-
teric artery bypass. Four patients required long-term hemodialysis. Postopera-
tive computed tomography scan showed a type II endoleak in two patients.1472Conclusions: Morbidity and mortality in this study were greater than
previously reported. Candidates for hybrid aortic repair should be carefully
selected.
Rapamycin Limits the Growth of Established Experimental Abdominal
Aortic Aneurysms
Rouer M., Xu B.H., Xuan H.J., Tanaka H., Fujimura N., Glover K.J.,
Furusho Y., Gerritsen M., Dalman R.L. Eur J Vasc Endovasc Surg
2014;47:493-500.
Objectives: Abdominal aortic aneurysm (AAA) is a chronic inﬂamma-
tory disease affecting 4-8% of men older than 60 years. No pharmacologic
strategies limit disease progression, aneurysm rupture, or aneurysm-related
death. We examined the ability of rapamycin to limit the progression of
established experimental AAAs.
Methods: AAAs were created in 10-12-week-old male C57BL/6J
mice via the porcine pancreatic elastase (PPE) infusion method. Beginning
4 days after PPE infusion, mice were treated with rapamycin (5 mg/kg/
day) or an equal volume of vehicle for 10 days. AAA progression was moni-
tored by serial ultrasound examination. Aortae were harvested for histolog-
ical analyses at sacriﬁce.
Results: Three days after PPE infusion, prior to vehicle or rapamycin
treatment, aneurysms were enlarging at an equal rate between groups. In
the rapamycin group, treatment reduced aortic enlargement by 38%, and
53% at 3 and 10 days, respectively. On histological analysis, medial elastin
and smooth muscle cell populations were relatively preserved in the rapamy-
cin group. Rapamycin treatment also reduced mural macrophage density
and neoangiogenesis.
Conclusion: Rapamycin limits the progression of established experi-
mental aneurysms, increasing the translational potential of mechanistic
target of rapamycin-related AAA inhibition strategies.
Early and Long-term Results After Reconstructive Surgery in 42
Children and Two Young Adults With Renovascular Hypertension
Due to Fibromuscular Dysplasia and Middle Aortic Syndrome
Sandmann W., Dueppers P., Pourhassan S., Voiculescu A., Klee D.,
Balzer K.M. Eur J Vasc Endovasc Surg 2014;47:509-16.
Objectives: This retrospective study presents the early and late results
of pediatric patients who underwent reconstructive surgery for renovascular
hypertension (RVH) between 1979 and 2009.
Methods: From 1979 to 2009 44 patients (male 22; mean age 13 6
5.2 years, range 1-19 years; early childhood 7 [1-6 years], middle child-
hood 5 [7-10 years]; adolescents 32 [11-19 years]) with renovascular hy-
pertension underwent surgery for abdominal aortic stenoses (n = 6), renal
artery stenosis (RAS) (n = 25) or for combined lesions (n = 13). Nineteen
aortic stenoses (bypass/interposition 10/5, patch dilatation/thromboen-
darterectomy 2/2), 51 renal arteries (interposition 36, resection þ reim-
plantation 13, patch dilatation/aneurysmorraphy 1 each), and 10
visceral arteries (resection þ reimplantation 6, interposition 3, patch dila-
tation 1) were reconstructed. Each patient underwent duplex studies and if
required intra-arterial digital subtraction angiography. Reoperations
within 30 postoperative days were required in four (9%) of the patients
for occlusion of four arteries (6%), achieving a combined technical success
rate of 94%.
Results: After 114 6 81 months 36 patients were re-examined by
duplex and magnetic resonance angiography (2 not surgery-related deaths
7/12 years postoperatively, 8 patients lived abroad). Twelve patients had
required a second and three a third procedure. Hypertension was cured
early/late postoperatively in 27%/56%, improved in 41%/44%, and
remained unchanged in 32%/0%. Best late results were obtained in patients
with isolated aortic disease and at the age of middle childhood.
Conclusions: Reconstructive surgery for pediatric RVH yields good
results at every age and every type of lesion. However, these children should
be followed up closely and to avoid early cardiovascular disease and death in
later life, surgery should not be delayed.
